Oral Findings In A Group of Egyptian Children With Attention Deficit Hyperactivity Disorder

NCT ID: NCT03887039

Last Updated: 2019-04-16

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 78 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2019-08-31
• Study Completion Date: 2020-07-31

Brief Summary

Attention-deficit/hyperactivity disorder is the most common childhood neuro-developmental disorder that is characterized by inattention, hyperactivity, and impulsivity. These symptoms last till adulthood in 65% of cases. ADHD has been reported to have a worldwide prevalence of 5.3% and it is more common in boys than in girls (Ghanizadeh 2008; Serra-Negra et al. 2012 and Shooshtari et al. 2013) The symptoms of ADHD are generally treated through behavioral therapy, with or without pharmacological intervention. Medications prescribed are commonly divided into stimulant or non-stimulant drugs. The stimulant medications (such as methylphenidate and amphetamines) have been implicated in adverse oral effects, such as xerostomia and gingival enlargement. The current evidence is controversial regarding the severity and prevalence of dental caries, dental trauma, periodontal diseases, oral habits and tooth wear among patients with ADHD (Chau et al. 2017).

In the Arab world, few studies have been published on ADHD. Accordingly, in the Arab society and Egypt there are limited data regarding the oral findings of children with ADHD. Owing to the sparsity of these data, this study will be conducted to evaluate different oral characteristics of Egyptian children with ADHD.

Detailed Description

Due to lack of published studies about the oral findings of Egyptian Children with ADHD, this study will be conducted to cover this point.

Conditions

Oral Manifestations

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

ADHD group

clinical examination

clinical examination

Intervention Type: OTHER

clinical examination for all the oral findings

normal group

clinical examination

clinical examination

Intervention Type: OTHER

clinical examination for all the oral findings

Interventions

clinical examination

clinical examination for all the oral findings

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• - Egyptian children 3-6 years old diagnosed with ADHD.
• Patients taking medications for the treatment of ADHD or not.
• Both male and female patients will be included.

Control Group:

A matched group of healthy children aged 3-6 years old.

Exclusion Criteria

• - Non-Egyptian children.
• Patients having systemic disorders, such as cerebral palsy or Down's syndrome.
• Patients complaining from any systemic disease

• Minimum Eligible Age: 3 Years
• Maximum Eligible Age: 6 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Cairo University

OTHER

Sponsor Role: lead

Responsible Party

Sara Gaber Hussien

Principal investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Sara G Hussien, BSc

Role: PRINCIPAL_INVESTIGATOR

Resident at pediatric Dentistry and Dental Public Health Department

Randa Y Abdel Gawad, PhD

Role: STUDY_DIRECTOR

Associate professor at pediatric Dentistry and Dental Public Health Department

Central Contacts

sara G hussien, BSc

Role: CONTACT

Sara.Gaber@dentistry.cu.edu.eg

00201012120090

Randa Yo Abdel Gawad, PhD

Role: CONTACT

00201222272010

Other Identifiers

14422016496994

Identifier Type: -

Identifier Source: org_study_id